| COMPOSITION: | Each uncoated Sustained release tablet contains Metformin Hydrochloride 1000 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Dailyglim tablets contain Metformin in sustain release form that acts by reducing the blood sugar. It is prescribed as a first line drug in diabetes and as an adjunct to other treatment when proper control is not there. |
| SIDE EFFECTS: | The most common adverse reactions are nausea, vomiting, diarrhoea, abdominal pain and loss of appetite. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
